Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYB004 in adults aged 40 years and older
NCT07311148Phase 2Active, not recruiting
- Sponsor
- Patronus Biotech
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of LYB004 in herpes zoster (HZ), sponsored by Patronus Biotech. Started Oct 2025; status: active, not recruiting.
02
Drugs
LYB004
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT07311148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311148.